301 related articles for article (PubMed ID: 32378300)
1. Omalizumab for treatment of refractory severe atopic dermatitis. A pediatric perspective.
Iannelli M; Caminiti L; Vaccaro M; Marafioti I; Spinuzza A; Panasiti I; Barbalace A; Crisafulli G; Pajno GB
Dermatol Ther; 2020 Jul; 33(4):e13519. PubMed ID: 32378300
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of simultaneously occurring urticaria and atopic dermatitis with dupilumab].
Föhr J; Herbst M; Jahn S
Hautarzt; 2021 Mar; 72(3):249-251. PubMed ID: 32856123
[TBL] [Abstract][Full Text] [Related]
3. Management of Atopy with Dupilumab and Omalizumab in CADINS Disease.
Diaz-Cabrera NM; Bauman BM; Iro MA; Dabbah-Krancher G; Molho-Pessach V; Zlotogorski A; Shamriz O; Dinur-Schejter Y; Sharon TD; Stepensky P; Tal Y; Eisenstein EM; Pietzsch L; Schuetz C; Abreu D; Coughlin CC; Cooper MA; Milner JD; Williams A; Armoni-Weiss G; Snow AL; Leiding JW
J Clin Immunol; 2024 Jan; 44(2):48. PubMed ID: 38231347
[TBL] [Abstract][Full Text] [Related]
4. Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy.
Velling P; Skowasch D; Pabst S; Jansen E; Tuleta I; Grohé C
Eur J Med Res; 2011 Sep; 16(9):407-10. PubMed ID: 22024441
[TBL] [Abstract][Full Text] [Related]
5. [Omalizumab as a therapeutic option in atopic eczema. Current evidence and potential benefit].
Schmitt J; Schäkel K
Hautarzt; 2007 Feb; 58(2):128, 130-2. PubMed ID: 17237929
[TBL] [Abstract][Full Text] [Related]
6. Immunobiologic treatments for severe asthma, atopic dermatitis, and chronic urticaria.
Chiarella SE
Allergy Asthma Proc; 2019 Nov; 40(6):485-489. PubMed ID: 31690400
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis.
Incorvaia C; Pravettoni C; Mauro M; Yacoub MR; Tarantini F; Riario-Sforza GG
Monaldi Arch Chest Dis; 2008 Jun; 69(2):78-80. PubMed ID: 18837422
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
[TBL] [Abstract][Full Text] [Related]
9. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial.
Chan S; Cornelius V; Chen T; Radulovic S; Wan M; Jahan R; Lack G
Trials; 2017 Mar; 18(1):136. PubMed ID: 28330497
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab for the treatment of atopic dermatitis.
Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
[TBL] [Abstract][Full Text] [Related]
11. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
13. Omalizumab for atopic dermatitis: case series and a systematic review of the literature.
Holm JG; Agner T; Sand C; Thomsen SF
Int J Dermatol; 2017 Jan; 56(1):18-26. PubMed ID: 27337170
[TBL] [Abstract][Full Text] [Related]
14. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
[TBL] [Abstract][Full Text] [Related]
15. [Dermatological implications of omalizumab, an anti-IgE antibody].
Di Lucca-Chrisment J
Rev Med Suisse; 2015 Apr; 11(468):779-80, 782-3. PubMed ID: 26021140
[TBL] [Abstract][Full Text] [Related]
16. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
Amrol D
South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
[TBL] [Abstract][Full Text] [Related]
17. Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.
Kim DH; Park KY; Kim BJ; Kim MN; Mun SK
Clin Exp Dermatol; 2013 Jul; 38(5):496-500. PubMed ID: 23083013
[TBL] [Abstract][Full Text] [Related]
18. An update on biological therapies for pediatric allergic diseases.
Castagnoli R; De Filippo M; Votto M; Marseglia A; Montagna L; Marseglia GL; Licari A
Minerva Pediatr; 2020 Oct; 72(5):364-371. PubMed ID: 32686927
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab : other indications and unanswered questions.
Mankad VS; Burks AW
Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
[TBL] [Abstract][Full Text] [Related]
20. New biological treatments for asthma and skin allergies.
Eyerich S; Metz M; Bossios A; Eyerich K
Allergy; 2020 Mar; 75(3):546-560. PubMed ID: 31444793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]